333 related articles for article (PubMed ID: 37316169)
1. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease.
Luxenburger H; Thimme R
Gut; 2023 Sep; 72(9):1783-1794. PubMed ID: 37316169
[TBL] [Abstract][Full Text] [Related]
2. Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
Liu Y; Lu J; Zhan H; Yuan W; Li X; Kang H; Li H; Chen Y; Cheng L; Sun X; Zheng H; Wang W; Dai E; Li Y
Virol Sin; 2023 Oct; 38(5):723-734. PubMed ID: 37487943
[TBL] [Abstract][Full Text] [Related]
3. Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.
Song R; Yang C; Li Q; Wang J; Chen J; Sun K; Lv H; Yang Y; Liang J; Ye Q; Gao Y; Li J; Li Y; Yan J; Liu Y; Wang T; Liu C; Zhu P; Wang F; Yin W; Xiang H
Front Immunol; 2023; 14():1200198. PubMed ID: 37398662
[TBL] [Abstract][Full Text] [Related]
4. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
5. Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.
Ai J; Wang J; Liu D; Xiang H; Guo Y; Lv J; Zhang Q; Li J; Zhang X; Li Q; Liang J; Guo X; Feng Y; Liu L; Zhang X; Qin W; Wang X; Rao W; Zhang Q; Tian Q; Zhang Y; Xie F; Jiang S; Yan Y; Qiu Y; Wu H; Hou Z; Zhang N; Zhang A; Ji J; Yang J; Huang J; Zhao Z; Gu Y; Bian L; Zhang Z; Zou S; Ji H; Ge G; Du X; Hou A; Zhu Y; Cong Q; Xu J; Zu H; Wang Y; Yan Z; Yan X; BianBa Y; Ci Q; Zhang L; Yang S; Gao X; Zhong L; He S; Liu C; Huang Y; Liu Y; Xu D; Zhu Q; Xu X; Lv M; Zhang W; Qi X
Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1516-1524.e2. PubMed ID: 34942370
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination.
Moon AM; Webb GJ; García-Juárez I; Kulkarni AV; Adali G; Wong DK; Lusina B; Dalekos GN; Masson S; Shore BM; Barnes E; Barritt AS; Marjot T
Hepatol Commun; 2022 Apr; 6(4):889-897. PubMed ID: 34708575
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Vaccination in Patients with Chronic Liver Disease.
Schinas G; Polyzou E; Mitropetrou F; Pazionis A; Gogos C; Triantos C; Akinosoglou K
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560782
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus disease 2019 and the liver.
Esteban JP; Sobotka L; Rockey DC
Curr Opin Gastroenterol; 2022 May; 38(3):191-199. PubMed ID: 35275902
[TBL] [Abstract][Full Text] [Related]
9. Long-term antibody response to inactivated SARS-CoV-2 vaccination in patients with chronic liver disease: A multicenter study.
Yang Y; Li X; Zhao X; Liu Y; Zhao T; Zhu Q
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102150. PubMed ID: 37269896
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study.
Ge J; Digitale JC; Pletcher MJ; Lai JC;
Hepatology; 2023 Mar; 77(3):834-850. PubMed ID: 36799617
[TBL] [Abstract][Full Text] [Related]
11. Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases.
Chauhan M; Nzeako I; Li F; Thuluvath PJ
Ann Hepatol; 2022; 27(4):100702. PubMed ID: 35338012
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune liver diseases and SARS-CoV-2.
Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
[TBL] [Abstract][Full Text] [Related]
13. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
Thuluvath PJ; Robarts P; Chauhan M
J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection in patients with autoimmune hepatitis.
Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
16. Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
Simão AL; Palma CS; Izquierdo-Sanchez L; Putignano A; Carvalho-Gomes A; Posch A; Zanaga P; Girleanu I; Henrique MM; Araújo C; Degre D; Gustot T; Sahuco I; Spagnolo E; Carvalhana S; Moura M; Fernandes DA; Banales JM; Romero-Gomez M; Trifan A; Russo FP; Stauber R; Berenguer M; Moreno C; Gonçalves J; Cortez-Pinto H; Castro RE
JHEP Rep; 2023 May; 5(5):100697. PubMed ID: 36844943
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury.
Hackstein CP; Spitzer J; Symeonidis K; Horvatic H; Bedke T; Steglich B; Klein S; Assmus LM; Odainic A; Szlapa J; Kessler N; Beyer M; Schmithausen R; Latz E; Flavell RA; Garbi N; Kurts C; Kümmerer BM; Trebicka J; Roers A; Huber S; Schmidt SV; Knolle PA; Abdullah Z
J Hepatol; 2023 Jul; 79(1):150-166. PubMed ID: 36870611
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and liver disease.
Dufour JF; Marjot T; Becchetti C; Tilg H
Gut; 2022 Nov; 71(11):2350-2362. PubMed ID: 35701093
[TBL] [Abstract][Full Text] [Related]
19. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
Elife; 2023 Jan; 12():. PubMed ID: 36692910
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
Ge J; Pletcher MJ; Lai JC;
Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
